stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. MYO
    stockgist
    HomeTop MoversCompaniesConcepts
    MYO logo

    Myomo, Inc.

    MYO
    AMEX
    Healthcare
    Medical - Devices
    Burlington, MA, US184 employeesmyomo.com
    $0.67
    -0.01(-0.83%)

    Mkt Cap $26M

    $0.64
    $4.88

    52-Week Range

    At a Glance

    AI-generated

    Myomo, Inc.

    8-K
    Myomo, Inc. announced its financial results for the fourth quarter and full year on March 9, 2026. The 8-K filing includes Item 2.02 for results of operations and financial condition, and Exhibit 99.1 containing the press release.

    $26M

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees184
    Fundamentals

    How The Business Makes Money

    Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

    Industry Medical - Devices
    Activity

    What Changed Recently

    Financial Results
    Mar 8, 2026

    . Results of Operations and Financial Condition. On March 9, 2026, Myomo, Inc, (the "Company") announced its financial results for the fourth quarter and full y

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    ECORelectroCore, Inc.$6.80+3.03%$55M—
    MIRAMIRA Pharmaceuticals, Inc...$1.10+4.25%$46M-0.8
    NMTCNeuroOne Medical Technolo...$0.80-0.54%$40M-5.7
    POCIPrecision Optics Corporat...$4.28+6.73%$33M-4.9
    IGCIGC Pharma, Inc.$0.27-1.84%$26M—
    MLSSMilestone Scientific Inc.$0.29-2.88%$23M—
    HYPDHyperion DeFi, Inc.$3.23-1.22%$16M-0.1
    MODDModular Medical, Inc.$4.98-7.43%$11M-0.4
    Analyst View
    Company Profile
    CIK0001369290
    ISINUS62857J2015
    CUSIP62857J201
    Phone617 996 9058
    Address45 Blue Sky Dr., Burlington, MA, 01803, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice